Showing results (1-10 of 282) with videos related to
Sort By:
Pageof 29
Expert Review of Cardiovascular Therapy|November 11, 2009
Recent changes in the landscape of combination RAS blockadeBenjamin J Epstein, Steven M Smith, Rushab ChoksiPharmacotherapy|March 7, 2012
Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitusNiren K Shah, Wasim E Deeb, Rushab Choksi, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 19, 2013
SGLT-2 inhibitors and their potential in the treatment of diabetesRebecca F Rosenwasser, Senan Sultan, David Sutton, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 6, 2021
A Critical Review of the Efficacy and Safety of InclisiranJennifer Hardy, Stephanie Niman, Edward Pereira, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering AgentJennifer Hardy, Stephanie Niman, Rebecca F Goldfaden, et al.Drugs in R&D|March 27, 2021
A Review on the Efficacy and Safety of Oral SemaglutideStephanie Niman, Jennifer Hardy, Rebecca F Goldfaden, et al.Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2007
Drug evaluation: PSN-9301, a short-acting inhibitor of dipeptidyl peptidase IVBenjamin J EpsteinExpert Opinion on Pharmacotherapy|July 2, 2010
Improving blood pressure control rates by optimizing combination antihypertensive therapyBenjamin J EpsteinVascular Health and Risk Management|September 23, 2010
Aliskiren and valsartan combination therapy for the management of hypertensionBenjamin J EpsteinPharmacotherapy|May 28, 2004
Elevations in serum creatinine concentration: concerning or reassuring?Benjamin J EpsteinPageof 29